Yahoo
NasdaqCM - Delayed Quote USD

Nuvectis Pharma, Inc. (NVCT)

20.13 -0.16 (-0.79%)
At close: October 8 at 4:00:00 PM EDT
Trade NVCT on Coinbase
Chart Range Bar
Loading chart for NVCT
  • Previous Close 20.29
  • Open 20.08
  • Bid 14.79 x 200
  • Ask 20.93 x 100
  • Day's Range 19.67 - 20.42
  • 52 Week Range 5.55 - 29.27
  • Volume 179,390
  • Avg. Volume 215,429
  • Market Cap (intraday) 657.125M
  • Beta (5Y Monthly) -0.24
  • PE Ratio (TTM) --
  • EPS (TTM) -1.31
  • Earnings Date (est.) Nov 3, 2026
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est 35.40

Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.

www.nuvectis.com

16

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 10/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

NVCT
166.62%
S&P 500 (^GSPC)
13.44%

1-Year Return

NVCT
223.11%
S&P 500 (^GSPC)
14.98%

3-Year Return

NVCT
78.14%
S&P 500 (^GSPC)
80.23%

5-Year Return

NVCT
409.62%
S&P 500 (^GSPC)
76.83%

Earnings Trends

View More

Earnings Per Share (GAAP)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY26
Revenue --
Earnings -7.02M
Profit Margin 0.00%

Q3

FY25

Q4

FY25

Q1

FY26

Q2

FY26

-6M
-4M
-2M
0
0.0%

Analyst Insights

View More

Analyst Price Targets

30.00
35.40 Average
20.13 Current
40.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/24/2026
Analyst HC Wainwright & Co.
Rating Action Reiterates
Rating Buy
Price Action Maintains
Price Target 39 -> 39

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    686.18M

  • Enterprise Value

    664.02M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    75.55

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -73.07%

  • Return on Equity (ttm)

    -214.58%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -30.27M

  • Diluted EPS (ttm)

    -1.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    22.16M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -8.89M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Company Insights

Fair Value

20.13 Current

Dividend Score

0 Low
Sector Avg.
100 High

Hiring Score

0 Low
Sector Avg.
100 High

Insider Sentiment Score

0 Low
Sector Avg.
100 High

Research Reports

View More
  • Daily – Vickers Top Buyers & Sellers for 07/02/2026

    The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.

  • Daily – Vickers Top Insider Picks for 10/31/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 10/30/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

  • Daily – Vickers Top Insider Picks for 10/27/2023

    The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: